2-(4-methylsulfonylphenyl)imidazo[1,2-a]pyridine

Suppliers

Names

[ CAS No. ]:
1222-57-7

[ Name ]:
2-(4-methylsulfonylphenyl)imidazo[1,2-a]pyridine

[Synonym ]:
Zolimidine
Zolimidin
EINECS 214-947-4

Chemical & Physical Properties

[ Density]:
1.31 g/cm3

[ Molecular Formula ]:
C14H12N2O2S

[ Molecular Weight ]:
272.32

[ Exact Mass ]:
272.06200

[ PSA ]:
59.82000

[ LogP ]:
3.48560

[ Index of Refraction ]:
1.653

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
NJ5758500
CHEMICAL NAME :
Imidazo(1,2-a)pyridine, 2-(p-(methylsulfonyl)phenyl)-
CAS REGISTRY NUMBER :
1222-57-7
BEILSTEIN REFERENCE NO. :
0752451
LAST UPDATED :
199712
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C14-H12-N2-O2-S
MOLECULAR WEIGHT :
272.34
WISWESSER LINE NOTATION :
T56 AN DNJ CR DSW1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
3710 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #3318880
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
950 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 33,1655,1983
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
4400 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
FMXXAJ French Medicament Patent Document. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Discontinued. Volume(issue)/page/year: #8177M
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
765 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
FMXXAJ French Medicament Patent Document. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Discontinued. Volume(issue)/page/year: #8177M

Safety Information

[ HS Code ]:
2933990090

Synthetic Route

Customs

[ HS Code ]: 2933990090

[ Summary ]:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%


Related Compounds

  • 2-(4-methylsulfonylphenyl)imidazo[1,2-a]pyridine,hydrochloride
  • 5-methyl-2-(4-methylsulfonylphenyl)imidazo[1,2-a]pyridine,hydrochloride
  • 2-(4-methylsulfonylphenyl)imidazo[1,2-a]pyridin-3-amine,hydrochloride
  • 2-[p-(Methylsulfonyl)phenyl]imidazo[1,2-a]pyridine-3-acetamide
  • 4-[[2-(4-methylsulfonylphenyl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine,hydrochloride
  • trimethyl-[[2-(4-methylsulfonylphenyl)imidazo[1,2-a]pyridin-3-yl]methyl]azanium,iodide
  • N-(6-((2-((5-ethyl-1,3,4-thiadiazol-2-yl)amino)-2-oxoethyl)thio)pyridazin-3-yl)cyclopropanecarboxamide
  • N-{6-[(2-oxo-2-phenylethyl)sulfanyl]pyridazin-3-yl}cyclopropanecarboxamide
  • N-(6-{[(4-methylphenyl)methyl]sulfanyl}pyridazin-3-yl)cyclopropanecarboxamide
  • N-(6-{[(pyridin-2-yl)methyl]sulfanyl}pyridazin-3-yl)cyclopropanecarboxamide
  • N-[6-({[(2,4-difluorophenyl)carbamoyl]methyl}sulfanyl)pyridazin-3-yl]cyclopropanecarboxamide
  • N-[6-({[(3-acetylphenyl)carbamoyl]methyl}sulfanyl)pyridazin-3-yl]cyclopropanecarboxamide
  • N-(6-((2,5-dimethylbenzyl)thio)pyridazin-3-yl)cyclopropanecarboxamide
  • N-{6-[({[4-(propan-2-yl)phenyl]carbamoyl}methyl)sulfanyl]pyridazin-3-yl}cyclopropanecarboxamide
  • N-[6-({[(3,4-difluorophenyl)carbamoyl]methyl}sulfanyl)pyridazin-3-yl]cyclopropanecarboxamide
  • N-[(Dimethylamino)sulfonyl]-L-isoleucine
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.